We are live on
!
Find out more
CC
Corton Capital Portfolio holdings
AUM
$40.7M
1-Year Est. Return
52.32%
This Fund
S&P 500
This Quarter
Est. Return
+15.1%
1 Year Est. Return
+52.32%
3 Year Est. Return
+225.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$213M
AUM Growth
+$68.7M
(+48%)
Cap. Flow
+$47.4M
Cap. Flow
% of AUM
22.27%
Top 10 Holdings %
Top 10 Hldgs %
28.96%
Holding
538
New
222
Increased
132
Reduced
66
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.35M |
| 2 |
NextEra Energy
NEE
|
+$1.28M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1.19M |
| 4 |
MGM Resorts International
MGM
|
+$1.1M |
| 5 |
H&R Block
HRB
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.04M |
| 2 |
KLA
KLAC
|
+$843K |
| 3 |
ZIM Integrated Shipping Services
ZIM
|
+$790K |
| 4 |
Vistra
VST
|
+$734K |
| 5 |
Cheniere Energy
LNG
|
+$729K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.1% |
| 2 | Healthcare | 12.95% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Financials | 8.23% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
CRISPR Therapeutics
CRSP
$4.68B
| $286K | 0.13% |
5,096
+214
| +4% | +$12.1K |
|
227
Alkermes
ALKS
$8.47B
| $285K | 0.13% |
+9,114
| New | +$276K |
|
228
Ionis Pharmaceuticals
IONS
$9.14B
| $284K | 0.13% |
6,929
-2,111
| -23% | -$81.1K |
|
229
Burlington
BURL
$23.3B
| $282K | 0.13% |
+1,792
| New | +$308K |
|
230
Ultragenyx Pharmaceutical
RARE
$2.56B
| $280K | 0.13% |
+6,062
| New | +$281K |
|
231
Idacorp
IDA
$8.24B
| $278K | 0.13% |
+2,708
| New | +$291K |
|
232
Telephone and Data Systems
TDS
$3.87B
| $277K | 0.13% |
+33,651
| New | +$285K |
|
233
Ryman Hospitality Properties
RHP
$8.58B
| $277K | 0.13% |
+2,978
| New | +$274K |
|
234
Nurix Therapeutics
NRIX
$2.51B
| $276K | 0.13% |
+27,613
| New | +$282K |
|
235
RXO
RXO
$3.73B
| $275K | 0.13% |
+12,120
| New | +$244K |
|
236
HEICO Corp
HEI
$50.8B
| $274K | 0.13% |
+1,548
| New | +$261K |
|
237
First Horizon
FHN
$12.3B
| $274K | 0.13% |
+24,291
| New | +$325K |
|
238
Entrada Therapeutics
TRDA
$226M
| $274K | 0.13% |
+18,067
| New | +$249K |
|
239
Sprout Social
SPT
$522M
| $273K | 0.13% |
+5,916
| New | +$281K |
|
|
CMA
240
DELISTED
Comerica
CMA
| $273K | 0.13% |
+6,446
| New | +$260K |
|
241
NRG Energy
NRG
$26.9B
| $272K | 0.13% |
+7,283
| New | +$248K |
|
|
NEX
242
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $272K | 0.13% |
+30,435
| New | +$251K |
|
243
Nucor
NUE
$60.5B
| $271K | 0.13% |
1,651
+174
| +12% | +$25.4K |
|
244
Charles River Laboratories
CRL
$11.6B
| $269K | 0.13% |
+1,281
| New | +$255K |
|
|
NARI
245
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $268K | 0.13% |
+4,616
| New | +$291K |
|
246
Oxford Industries
OXM
$613M
| $268K | 0.13% |
+2,718
| New | +$278K |
|
247
Privia Health
PRVA
$3.13B
| $265K | 0.12% |
10,158
+1,749
| +21% | +$46.2K |
|
248
Acushnet Holdings
GOLF
$6.05B
| $264K | 0.12% |
+4,836
| New | +$239K |
|
249
Keysight
KEYS
$52.2B
| $263K | 0.12% |
+1,569
| New | +$243K |
|
250
Teladoc Health
TDOC
$1.69B
| $263K | 0.12% |
+10,371
| New | +$261K |
|
Similar funds
NLVP
BAM
MAM
AM
WCPI
OC
HCM
PI
Corton Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Corton Capital held 538 positions worth $213M, up 48% from $144M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Corton Capital deployed $47.4M of net new capital in Q2 2023, opening 222 new positions and adding to 132 existing holdings. Its largest new stake was NVIDIA: 40,640 shares worth $1.72M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 42% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was DraftKings, an estimated $655K trimmed.
- Corton Capital's largest Q2 2023 buy was NVIDIA: 40,640 shares worth $1.72M.
- Corton Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $786K increase.
- Corton Capital's biggest Q2 2023 reduction was DraftKings, cutting an estimated $655K.
- Corton Capital fully exited Lam Research in Q2 2023, selling an estimated $1.04M.
- Corton Capital's ten largest holdings make up 29% of its $213M portfolio in Q2 2023.
- Corton Capital opened 222 new positions and closed 117 in Q2 2023.
- Corton Capital's portfolio value rose 48% quarter-over-quarter to $213M.
Based on Corton Capital's 13F filing for Q2 2023, filed 14 Aug 2023.